These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30529227)

  • 41. Advanced tests for early and accurate diagnosis of Creutzfeldt-Jakob disease.
    Zanusso G; Monaco S; Pocchiari M; Caughey B
    Nat Rev Neurol; 2016 Jun; 12(6):325-33. PubMed ID: 27174240
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions.
    Franceschini A; Baiardi S; Hughson AG; McKenzie N; Moda F; Rossi M; Capellari S; Green A; Giaccone G; Caughey B; Parchi P
    Sci Rep; 2017 Sep; 7(1):10655. PubMed ID: 28878311
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Amplification techniques and diagnosis of prion diseases.
    Brandel JP; Culeux A; Grznarova K; Levavasseur E; Lamy P; Privat N; Welaratne A; Denouel A; Laplanche JL; Haik S
    Rev Neurol (Paris); 2019; 175(7-8):458-463. PubMed ID: 31296398
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cerebrospinal fluid non-phosphorylated tau in the differential diagnosis of Creutzfeldt-Jakob disease: a comparative prospective study with 14-3-3.
    Llorens F; Villar-Piqué A; Hermann P; Schmitz M; Goebel S; Waniek K; Lachmann I; Zerr I
    J Neurol; 2020 Feb; 267(2):543-550. PubMed ID: 31701333
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High Diagnostic Accuracy of RT-QuIC Assay in a Prospective Study of Patients with Suspected sCJD.
    Fiorini M; Iselle G; Perra D; Bongianni M; Capaldi S; Sacchetto L; Ferrari S; Mombello A; Vascellari S; Testi S; Monaco S; Zanusso G
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019068
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neurofilament light chain and tau concentrations are markedly increased in the serum of patients with sporadic Creutzfeldt-Jakob disease, and tau correlates with rate of disease progression.
    Thompson AGB; Luk C; Heslegrave AJ; Zetterberg H; Mead SH; Collinge J; Jackson GS
    J Neurol Neurosurg Psychiatry; 2018 Sep; 89(9):955-961. PubMed ID: 29487167
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnosis of Human Prion Disease Using Real-Time Quaking-Induced Conversion Testing of Olfactory Mucosa and Cerebrospinal Fluid Samples.
    Bongianni M; Orrù C; Groveman BR; Sacchetto L; Fiorini M; Tonoli G; Triva G; Capaldi S; Testi S; Ferrari S; Cagnin A; Ladogana A; Poleggi A; Colaizzo E; Tiple D; Vaianella L; Castriciano S; Marchioni D; Hughson AG; Imperiale D; Cattaruzza T; Fabrizi GM; Pocchiari M; Monaco S; Caughey B; Zanusso G
    JAMA Neurol; 2017 Feb; 74(2):155-162. PubMed ID: 27942718
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical Use of Improved Diagnostic Testing for Detection of Prion Disease.
    Figgie MP; Appleby BS
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33925126
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Real-time quaking-induced conversion assays for prions: Applying a sensitive but imperfect test in clinical practice.
    Jones SM; Lazar EB; Porter AL; Prusinski CC; Brier MR; Bucelli RC; Day GS
    Eur J Neurol; 2023 Jul; 30(7):1854-1860. PubMed ID: 36940265
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endpoint Quaking-Induced Conversion: a Sensitive, Specific, and High-Throughput Method for Antemortem Diagnosis of Creutzfeldt-Jacob Disease.
    Cheng K; Vendramelli R; Sloan A; Waitt B; Podhorodecki L; Godal D; Knox JD
    J Clin Microbiol; 2016 Jul; 54(7):1751-1754. PubMed ID: 27076662
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Prion diseases in The Netherlands: twenty-nine years of surveillance].
    Karamujić-Čomić H; Rozemuller AJM; Verbeek MM; Lemstra AW; Ikram MA; van Duijn CM
    Ned Tijdschr Geneeskd; 2022 Sep; 166():. PubMed ID: 36300478
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sporadic Fatal Insomnia in Europe: Phenotypic Features and Diagnostic Challenges.
    Abu-Rumeileh S; Redaelli V; Baiardi S; Mackenzie G; Windl O; Ritchie DL; Didato G; Hernandez-Vara J; Rossi M; Capellari S; Imperiale D; Rizzone MG; Belotti A; Sorbi S; Rozemuller AJM; Cortelli P; Gelpi E; Will RG; Zerr I; Giaccone G; Parchi P
    Ann Neurol; 2018 Sep; 84(3):347-360. PubMed ID: 30048013
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prion protein amplification techniques.
    Green AJE; Zanusso G
    Handb Clin Neurol; 2018; 153():357-370. PubMed ID: 29887145
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proteinase-activated receptor 2 and disease biomarkers in cerebrospinal fluid in cases with autopsy-confirmed prion diseases and other neurodegenerative diseases.
    Rohan Z; Smetakova M; Kukal J; Rusina R; Matej R
    BMC Neurol; 2015 Mar; 15():50. PubMed ID: 25886404
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cerebrospinal Fluid Biomarkers in the Diagnosis of Creutzfeldt-Jakob Disease in Slovak Patients: over 10-Year Period Review.
    Koscova S; Zakova Slivarichova D; Tomeckova I; Melicherova K; Stelzer M; Janakova A; Kosorinova D; Belay G; Mitrova E
    Mol Neurobiol; 2017 Oct; 54(8):5919-5927. PubMed ID: 27665282
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion.
    Atarashi R; Satoh K; Sano K; Fuse T; Yamaguchi N; Ishibashi D; Matsubara T; Nakagaki T; Yamanaka H; Shirabe S; Yamada M; Mizusawa H; Kitamoto T; Klug G; McGlade A; Collins SJ; Nishida N
    Nat Med; 2011 Feb; 17(2):175-8. PubMed ID: 21278748
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 14-3-3 and enolase abundances in the CSF of Prion diseased rats.
    Gushue D; Herbst A; Sim V; McKenzie D; Aiken JM
    Prion; 2018; 12(3-4):253-260. PubMed ID: 30149773
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The advances in the early and accurate diagnosis of Creutzfeldt-Jakob disease and other prion diseases: where are we today?
    Kishida H; Ueda N; Tanaka F
    Expert Rev Neurother; 2023; 23(9):803-817. PubMed ID: 37581576
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A case report of genetic prion disease with two different PRNP variants.
    Piazza M; Prior TW; Khalsa PS; Appleby B
    Mol Genet Genomic Med; 2020 Mar; 8(3):e1134. PubMed ID: 31953922
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tau, Glial Fibrillary Acidic Protein, and Neurofilament Light Chain as Brain Protein Biomarkers in Cerebrospinal Fluid and Blood for Diagnosis of Neurobiological Diseases.
    Park Y; Kc N; Paneque A; Cole PD
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.